Leonardo Brunetti (@brunet3leon) 's Twitter Profile
Leonardo Brunetti

@brunet3leon

Research Fellow @ImperialCollege. Oncology Resident @CampusBiomedico. #Immunotherapy enthusiast

ID: 388195414

calendar_today10-10-2011 10:39:54

17 Tweet

99 Followers

180 Following

Alessio Cortellini (@acortellinimd) 's Twitter Profile Photo

Beyond a shadow of a doubt periop-IO is the new SoC for early stage-NSCLC. We need to set the bar of multidisciplinarity higher. 👇reassuring recap Clinical Lung Cancer on surgical outcomes after #neoADJIO🎯 Surgery and Cancer UCBM Fondazione Policlinico Campus Bio-Medico clinical-lung-cancer.com/article/S1525-…

Alessio Cortellini (@acortellinimd) 's Twitter Profile Photo

Looking for a quick post #ESMO23 recap on #Breast, #Gynae and #Lung🤌🇮🇹 Check this AIOM webinar out👇👇aiom.it/eventi-aiom/20…

AIOM (@aiomtweet) 's Twitter Profile Photo

Seconda edizione dell’ASCO-AIOM International Clinical Research Course: come sempre grande partecipazione ed entusiasmo. #ASCO #AIOM ASCO

Seconda edizione dell’ASCO-AIOM International Clinical Research Course: come sempre grande partecipazione ed entusiasmo.
#ASCO #AIOM <a href="/ASCO/">ASCO</a>
Vivli (@vivlicenter) 's Twitter Profile Photo

Congratulations to Alessio Cortellini on your public disclosure, “Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials.” ascopubs.org/doi/10.1200/JC… Imperial College London

Alessio Cortellini (@acortellinimd) 's Twitter Profile Photo

"triplets" chemo-IO weren't tested in frail pts with #NSCLC and I have the feeling that sometime we're just delivering chemo baby(subtherapeutic)doses with no #RCT evidence⚠️Kudos to the Fondazione Policlinico Campus Bio-Medico UCBM lung team for this meticolous work tandfonline.com/doi/full/10.10…

Leonardo Brunetti (@brunet3leon) 's Twitter Profile Photo

Today I presented my first poster st #ESMO2024 about the dose-dependent disruptive effect of PPIs on immunotherapy outcomes in NSCLC. An infinite thank you to the best mentor and brand-new groom Alessio Cortellini and to my ever supporting darling Valentina Santo

Today I presented my first poster st #ESMO2024 about the dose-dependent disruptive effect of PPIs on immunotherapy outcomes in NSCLC. An infinite thank you to the best mentor and brand-new groom <a href="/ACortelliniMD/">Alessio Cortellini</a> and to my ever supporting darling <a href="/valentsant/">Valentina Santo</a>
Alessio Cortellini (@acortellinimd) 's Twitter Profile Photo

I had an excused absence from #ESMO24 💫🤵‍♂️👰‍♂️ but I'm still incredibly proud of the representation from the UCBM Fondazione Policlinico Campus Bio-Medico MedOnc Lung team 👇👇👇 Leonardo Brunetti @fabricitarella

I had an excused absence from #ESMO24 💫🤵‍♂️👰‍♂️ but I'm still incredibly proud of the representation from the <a href="/CampusBioMedico/">UCBM</a> <a href="/PoliclinCampus/">Fondazione Policlinico Campus Bio-Medico</a> MedOnc Lung team 👇👇👇
<a href="/Brunet3Leon/">Leonardo Brunetti</a> @fabricitarella
Alessio Cortellini (@acortellinimd) 's Twitter Profile Photo

More than 2 Years later, >60 centers, 14 countries and at least part of the #PembroReal5Y registry is seeing the light at #SITC2024 Huge thanks to our collaborators and looking forward to see the full text out! Fondazione Policlinico Campus Bio-Medico Surgery and Cancer UCBM Society for Immunotherapy of Cancer

More than 2 Years later, &gt;60 centers, 14 countries and at least part of the #PembroReal5Y registry is seeing the light at #SITC2024 
Huge thanks to our collaborators and looking forward to see the full text out!
<a href="/PoliclinCampus/">Fondazione Policlinico Campus Bio-Medico</a> <a href="/ImperialSandC/">Surgery and Cancer</a> <a href="/CampusBioMedico/">UCBM</a> <a href="/sitcancer/">Society for Immunotherapy of Cancer</a>
Alessio Cortellini (@acortellinimd) 's Twitter Profile Photo

Eventually, this titanic networking effort is out Journal for ImmunoTherapy of Cancer 🎯 If properly managed, RWE can be highly informative— in this GLOBAL 5-year cohort study of 1L pembro in #NSCLC we used ESMO - Eur. Oncology-GROW👇Recommended! UCBM Surgery and Cancer jitc.bmj.com/content/13/2/e…

Raffaele Califano (@caliraf) 's Twitter Profile Photo

Last week we had another great ESMO preceptorship in lung cancer at The Christie. I am deeply grateful to my co-chairs, all the speakers, delegates and the admin/technical team for making it a big success.

Last week we had another great ESMO preceptorship in lung cancer at The Christie. I am deeply grateful to my co-chairs, all the speakers, delegates and the admin/technical team for making it a big success.
Alessio Cortellini (@acortellinimd) 's Twitter Profile Photo

If you're at ESMO - Eur. Oncology #ELCC25, stop by board #192 p tomorrow! Our own Leonardo Brunetti will present a post hoc analysis of the PACIFIC trial, reporting for the 1st time on the potential detrimental effect of baseline atb/PPi on #IO maintenance following CTRT in NSCLC! UCBM

If you're at <a href="/myESMO/">ESMO - Eur. Oncology</a> #ELCC25, stop by board #192 p tomorrow! Our own <a href="/Brunet3Leon/">Leonardo Brunetti</a> will present a post hoc analysis of the PACIFIC trial, reporting for the 1st time on the potential detrimental effect of baseline atb/PPi on #IO maintenance following CTRT in NSCLC! <a href="/CampusBioMedico/">UCBM</a>
Valentina Santo (@valentsant) 's Twitter Profile Photo

Go check Leonardo Brunetti presenting the first results of our post-hoc analysis of the PACIFIC Trial on the differential impact of PPIs & antibiotics on clinical outcomes from IO, led by him and Alessio Cortellini ELCC 2025 Insights: vumedi.com/video/elcc-202… VuMedi

Biagio Ricciuti, MD, PhD (@bricciutimd) 's Twitter Profile Photo

Proud of Drs. #ValentinaSanto & #EleonoraGariazzo—talented, humble, & patient-centered—for presenting their work on biomarkers of response/resistance to #ICI in pts w/ #SqNSCLC (42) & w/o history of smoking (43) at #ASCO25. #IMG true force for progress. Rafeh Naqash, MD ASCO

Proud of Drs. #ValentinaSanto &amp; #EleonoraGariazzo—talented, humble, &amp; patient-centered—for presenting their work on biomarkers of response/resistance to #ICI in pts w/ #SqNSCLC (42) &amp; w/o history of smoking (43) at #ASCO25. 
#IMG true force for progress. <a href="/thenasheffect/">Rafeh Naqash, MD</a> <a href="/ASCO/">ASCO</a>
Valentina Santo (@valentsant) 's Twitter Profile Photo

Extremely grateful to have crossed paths with the best mentors I could have ever asked for. Their guidance, trust, and example continue to inspire me every day Biagio Ricciuti, MD, PhD Alessio Cortellini

Leonardo Brunetti (@brunet3leon) 's Twitter Profile Photo

Happy to share our latest work - the result of a collective effort by our Italian Lung Cancer Network group in Lazio! A concrete example of regional collaboration in clinical research! Valentina Santo mdpi.com/3379680 #mdpicancers via Cancers MDPI MDPI

Angela Lamarca (@drangelalamarca) 's Twitter Profile Photo

Best Poster Prize for “Hepatocellular and Non-Biliary Liver Cancer” at ESMO - Eur. Oncology #ESMOGI25 🏆Awarded to Pasquale Lombardi 👉Clinical refractoriness to AtezoBev in HCC Congratulations, very well defended piece of work 👏🏻👏🏻 #ESMOAmbassadors

Best Poster Prize for “Hepatocellular and Non-Biliary Liver Cancer” at <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI25

🏆Awarded to <a href="/paslombardi/">Pasquale Lombardi</a>
👉Clinical refractoriness to AtezoBev in HCC

Congratulations, very well defended piece of work 👏🏻👏🏻

#ESMOAmbassadors